First-in-human ex-vivo validation of carbonic anhydrase IX-PET for high-risk renal cancer (CAT-VHL - PRR-POC-2023-12377493)

Read full text Summarise with VIRAT
Authors: Alessandro Larcher, Fabrizia Gelardi, Lidija Antunovic, Annarita Savi, Michela Olivieri, Paolo Rainone, Martina Sollini, Rosa Maria Moresco, Chiara Re, Francesco Cei, Federico Belladelli, Giacomo Musso
+12 more L. Salerno, Francesco DE COBELLI, Nazario Pio Tenace, Maurilio Ponzoni, Antonio Cigliola, Paolo Verze, Roberto Bertini, Alberto Briganti, Francesco Montorsi, Umberto Capitanio, Andrea Salonia, Arturo Chiti
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Dataset, scanner characteristics, acquisition protocol, and images including: Axial in-vivo CAIX-PET/CT and standard contrast-enhanced CT images in three patients with high-risk renal cancer. CAIX-PET demonstrated significant albeit spatially heterogeneous uptake in the primary renal tumor in two cases later confirmed as pT3a renal cell carcinoma at final pathology. In one case, CAIX-PET was negative, with no significantly detectable tumor uptake. This finding was confirmed at final pathology as a pT3a chromophobe tumor. Macroscopic examination of the surgical specimen, ex-vivo imaging at preclinical PET/CT, hematoxylin and eosin staining and immunohistochemistry staining for CAIX in a patient diagnosed with a pT3a G3 clear cell renal cell carcinoma following robot-assisted radical nephrectomy. Axial standard chest CT images and CAIX-PET images of case 2. CAIX-PET prompted the reclassification from cM0 to cM1 by detecting pathological radiopharmaceutical uptake in the fourth rib. Following surgical metastasectomy, final pathology confirmed the presence of osseous trabeculae interspersed with richly vascularized neoplastic tissue composed of cells with abundant clear cytoplasm, consistent with metastatic ccRCC. This study is funded by the European Union - Next Generation EU - NRRP M6C2 - Investment 2.1 Enhancement and strengthening of biomedical research in the NHS - PNRR-POC-2023-12377493; cup master C43C24000360007.

Fields of Study & Subjects

Medical Imaging Techniques and Applications Renal cell carcinoma treatment Cancer Hypoxia and Metabolism

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
17 March 2026
Language
EN
Document type
Dataset